Pfizer, Astellas and J&J envision a wide-open new field for patients whose prostate cancer hasn’t yet spread, and they’ve got data that could open the gates.
BMS’ Opdivo and Yervoy combo better than chemo in halting lung cancer progression
Bristol-Myers Squibb has revealed promising data from its ongoing Phase 3 study investigating the efficacy of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) compared to chemotherapy in the first-line...
In diabetes war, Novo Nordisk aims to break mold with new pill
After nearly a century building a company worth $125 billion based on injectable drugs, Denmark’s Novo Nordisk – the world’s biggest insulin maker – wants to prove this year it can transform the...
Abbott teams up with Angle for metastatic breast cancer study
Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast cancer, it has emerged.
Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years
Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator...
Array BioPharma demands $192m after AstraZeneca refuses to pay royalties
Array BioPharma has launched a lawsuit against AstraZeneca over allegations the latter has refused to pay royalties it owes for cancer drug selumetinib and is demanding at least $192 million from the pharma giant...
5 brands share their content marketing process
It’s a hazard of the job for content marketers. When you read or see a piece of high-quality content, you wonder how it got created. You ask yourself, “What does this company do to create great content? Is it great for...
Merck KGaA puts devices to work against diabetes in Blue Mesa digital program
The latest entrant into the digital diabetes arena is Merck KGaA. The Glucophage maker has teamed with digital healthcare provider Blue Mesa Health to target people recently diagnosed with prediabetes and help...
Hoe ben je echt klaar voor mobile-first index?
Als je ondanks alle blogs over de mobile-first index nog geen actie hebt ondernomen, is dat waarschijnlijk omdat jouw website goed is ingericht. Althans, daar ga je vanuit. Maar heb je dit ook daadwerkelijk...
Rapidly-growing Nektar Therapeutics reportedly considering sale of its business
After a slew of M&A deals throughout the first month of 2018, including Celgene’s buyout of Juno Therapeutics for $9 billion and Sanofi’s spending spree to acquire Bioverativ for $11.6 billion and Ablynx for $4.8...
UK GPs are undervalued; with 40% looking to quit profession, study finds
Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in an increasingly complex health environment”, and a feeling general practice-based primary...
Merck celebrates its 350th anniversary
Merck, a leading science and technology company, will celebrate its 350th anniversary this year with customers, partners and employees under the motto “Past. Present. Future.” In 1668, the pharmacist...
Wat is de invloed van Google AdWords (SEA) op organische rankings (SEO)?
Het eerste wat je leert als beginnend marketeer is dat er binnen Google twee grootmachten zijn: SEO en SEA. Op het eerste oog lijken deze als Yin en Yang – bij SEA koop je je in, terwijl je je plek binnen de organische...
Pfizer teams up with Indian Government to battle antimicrobial resistance
Pfizer has entered into a partnership with the Indian Council of Medical Research (ICMR) in an effort to fight antimicrobial resistance (AMR) in India, establishing a centre in New Delhi as part of the project.
EU proposes joint studies to speed acceptance of new medicine
The European Commission proposed on Wednesday joint clinical assessments to determine whether approved new drugs and medical devices offer value for money and should be prescribed for patients within national healthcare...
Ipsen promotes new CMO from within
Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current position as SVP, Head of Global Medical Affairs. The promotion represents a...
‘Te weinig cardiologen hebben verstand van het vrouwenhart’
Vrouwen met hartklachten moeten lang wachten voordat ze terecht kunnen bij cardiologen die extra aandacht voor en verstand hebben van het vrouwenhart. De wachttijden kunnen oplopen tot een jaar. ...
Meeste nabestaanden weigeren orgaandonatie; verandert een nieuwe wet dat?
Komt er wel of geen nieuw donorregistratiesysteem? Morgen debatteert de Eerste Kamer over het wetsvoorstel van D66’er Pia Dijkstra.



![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)




